Form D — ADvantage Therapeutics, Inc.
0001869338-25-000001 · filed 2025-07-28
Offering
- Industry
- Other Health Care
- Exemptions
- 06b
- Total offering
- $25,449,956
- Total sold
- $13,737,491
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- ADvantage Therapeutics, Inc.
- CIK
- 1869338
- Entity
- Corporation
- Jurisdiction
- DELAWARE
- Year incorporated
- 2021
- Address
- 195 NW 40th Street
Miami, FL 33140 - Phone
- 630-886-7345
Related persons
May not be accurate — issuers self-report this list and the SEC does not verify it. Cross-check the original SEC EDGAR filing if accuracy matters.
-
Agustin Fernandez Santana III · Executive OfficerMiami, FL Find on LinkedIn ↗
-
Jeffrey B. Madden · Executive OfficerMiami, FL Find on LinkedIn ↗
-
Frank Mattner · DirectorMiami, FL Find on LinkedIn ↗
-
Walter Schmidt · DirectorMiami, FL Find on LinkedIn ↗
-
David Buchsbaum · Executive OfficerMiami, FL Find on LinkedIn ↗
View original on SEC EDGAR.